Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2019 December;44(4) > Minerva Endocrinologica 2019 December;44(4):417-9

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

LETTERS TO THE EDITOR   

Minerva Endocrinologica 2019 December;44(4):417-9

DOI: 10.23736/S0391-1977.19.03063-3

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: English

MiR-29 alleviates renal fibrosis in hypertension rats through inhibiting AKT signaling pathway

Jingyun OU 1, 2, Guoming YU 3, Xiaojun TAN 1, Haihong ZHANG 1, Bo HU 2, Dexu HUNAG 2, Yunyi LI 2, Lianghong YIN 2

1 Department of Nephrology, Kaiping Central Hospital, Kaiping, China; 2 Department of Nephrology, The First Affiliated Hospital of Jinan University, Guangzhou, China; 3 Department of Nephrology, the Affiliated Shunde Hospital of Jinan University, Foshan, China



top of page